AU
UK
CA
NZ
IND
US
Last update at 2026-06-09T15:57:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Assessing TransMedics Group And Two Other Stocks That Might Be Trading Below Estimated Value
Wed 21 May 25, 05:41 PM3 Prominent Stocks Estimated To Be Trading Below Intrinsic Value By Up To 46.9%
Mon 19 May 25, 05:45 PM3 Stocks Estimated To Be Trading Up To 49.2% Below Intrinsic Value
Mon 19 May 25, 11:44 AM3 Noteworthy Stocks Estimated To Be Up To 35.6% Below Intrinsic Value
Fri 16 May 25, 05:44 PMValue Opportunities: Stocks Estimated Below Intrinsic Worth For May 2025
Fri 16 May 25, 11:44 AMExploring May 2025's Undervalued Small Caps With Insider Action
Thu 15 May 25, 11:39 AMQuaker Chemical (KWR) Reliance on International Sales: What Investors Need to Know
Tue 13 May 25, 01:16 PMVerra Mobility And 2 Other Stocks That May Be Priced Below Their Estimated Value
Fri 09 May 25, 05:37 PM3 Stocks Estimated To Be Up To 49.4% Below Intrinsic Value
Mon 05 May 25, 05:37 PM3 Stocks That May Be Undervalued By Up To 49.7%
Mon 05 May 25, 11:40 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 7.12M | 146.99M | 27.14M | 28.90M | 83.10M |
| Minority interest | -0.08900M | -0.06200M | 0.13M | 0.26M | 0.34M |
| Net income | -17.80700M | 121.37M | 39.66M | 31.62M | 59.47M |
| Selling general administrative | 455.41M | 418.86M | 380.75M | 283.83M | 207.87M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 612.65M | 594.64M | 513.44M | 392.12M | 312.31M |
| Reconciled depreciation | 80.47M | 86.55M | 83.25M | 44.90M | 19.71M |
| Ebit | 144.64M | 150.47M | 60.97M | 108.03M | 105.92M |
| Ebitda | 225.11M | 281.19M | 144.21M | 152.93M | 125.63M |
| Depreciation and amortization | 80.47M | 130.72M | 83.25M | 44.90M | 19.71M |
| Non operating income net other | -10.64200M | 28.23M | 1.73M | 4.81M | 3.24M |
| Operating income | 144.64M | 150.47M | 136.04M | 108.03M | 87.78M |
| Other operating expenses | 1786.34M | 1585.37M | 1281.64M | 1025.21M | 763.08M |
| Interest expense | 32.58M | 22.33M | 26.60M | 16.98M | 6.16M |
| Tax provision | 24.93M | 34.94M | -5.29600M | 2.08M | 25.05M |
| Interest income | 41.98M | 26.15M | 32.69M | 16.75M | 2.12M |
| Net interest income | -32.57900M | -22.32600M | -26.60300M | -16.97600M | -4.04100M |
| Extraordinary items | - | - | - | - | -7.90000M |
| Non recurring | 104.94M | 25.32M | 73.33M | 62.16M | 16.66M |
| Other items | - | - | - | - | - |
| Income tax expense | 24.93M | 34.94M | -5.29600M | 2.08M | 25.05M |
| Total revenue | 1943.59M | 1761.16M | 1417.68M | 1133.50M | 867.52M |
| Total operating expenses | 455.41M | 418.86M | 377.41M | 283.83M | 207.87M |
| Cost of revenue | 1330.93M | 1166.52M | 904.23M | 741.39M | 555.21M |
| Total other income expense net | -137.52100M | -3.47500M | 108.90M | -79.13100M | -17.30300M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -15.84200M | 121.43M | 32.44M | 26.82M | 58.05M |
| Net income applicable to common shares | -15.83900M | 121.37M | 39.66M | 31.62M | 59.47M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 2821.62M | 2955.76M | 2891.83M | 2850.32M | 709.66M |
| Intangible assets | 942.92M | 1027.78M | 1081.36M | 1121.77M | 63.58M |
| Earning assets | - | - | - | - | - |
| Other current assets | 55.44M | 59.87M | 50.16M | 41.52M | 18.13M |
| Total liab | 1543.04M | 1567.84M | 1570.92M | 1607.95M | 273.30M |
| Total stockholder equity | 1277.92M | 1387.29M | 1320.36M | 1240.76M | 435.05M |
| Deferred long term liab | 160.29M | 179.03M | 192.76M | 211.09M | 10.00M |
| Other current liab | 134.97M | 131.48M | 138.74M | 145.12M | 60.79M |
| Common stock | 17.95M | 17.90M | 17.85M | 17.73M | 13.34M |
| Capital stock | 17.95M | 17.90M | 17.85M | 17.73M | 13.34M |
| Retained earnings | 469.92M | 516.33M | 423.94M | 412.98M | 405.12M |
| Other liab | 227.72M | 274.62M | 311.82M | 333.89M | 85.89M |
| Good will | 515.01M | 631.19M | 631.21M | 607.21M | 83.33M |
| Other assets | 0.04M | -0.01800M | 48.36M | 191.91M | 39.00M |
| Cash | 180.96M | 165.18M | 181.83M | 123.52M | 104.15M |
| Cash and equivalents | 180.96M | 165.18M | 181.83M | 123.52M | 104.15M |
| Total current liabilities | 354.79M | 430.47M | 382.96M | 359.93M | 151.47M |
| Current deferred revenue | 6.58M | 7.96M | 6.38M | 5.55M | 2.19M |
| Net debt | 798.81M | 754.51M | 733.27M | 828.52M | -67.54300M |
| Short term debt | 19.25M | 56.94M | 38.97M | 38.33M | 0.67M |
| Short long term debt | 19.25M | 56.94M | 38.97M | 38.33M | 0.67M |
| Short long term debt total | 979.77M | 919.68M | 915.11M | 952.04M | 36.60M |
| Other stockholder equity | 928.29M | 917.05M | 905.17M | 888.22M | 97.30M |
| Property plant equipment | 242.36M | 234.16M | 203.88M | 213.47M | 83.92M |
| Total current assets | 994.14M | 920.25M | 792.73M | 715.97M | 418.51M |
| Long term investments | 88.23M | 95.28M | 95.78M | 93.82M | 21.32M |
| Net tangible assets | -180.01500M | -271.68200M | -392.20600M | -488.20800M | 288.14M |
| Short term investments | - | - | - | 93.82M | -12.88600M |
| Net receivables | 472.89M | 430.68M | 372.97M | 375.98M | 202.14M |
| Long term debt | 933.56M | 836.41M | 849.07M | 882.44M | 35.93M |
| Inventory | 284.85M | 264.53M | 187.76M | 174.95M | 94.09M |
| Accounts payable | 193.98M | 234.08M | 198.87M | 170.93M | 87.82M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | 0.67M | 0.63M | 0.55M | 1.60M | 1.32M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -138.24000M | -63.99000M | -26.59800M | -78.17000M | -80.71500M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | 17.95M | 17.90M | 17.85M | 17.73M | 13.34M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | 469.92M | 516.33M | 423.94M | 412.98M | 405.12M |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 27.74M | 30.96M | 31.80M | 40.43M | 32.05M |
| Deferred long term asset charges | - | - | - | 14.74M | 6.95M |
| Non current assets total | 1827.48M | 2035.51M | 2099.11M | 2134.34M | 291.15M |
| Capital lease obligations | 26.97M | 26.34M | 27.07M | 42.45M | - |
| Long term debt total | 933.56M | 836.41M | 849.07M | 882.44M | 35.93M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -40.19100M | -49.13000M | -71.38500M | -908.63200M | -12.35800M |
| Change to liabilities | -27.65900M | 38.00M | 15.33M | -19.18700M | 5.12M |
| Total cashflows from investing activities | -40.19100M | -49.13000M | -71.38500M | -908.63200M | -12.35800M |
| Net borrowings | 55.15M | 14.24M | -49.76100M | 864.59M | -26.79100M |
| Total cash from financing activities | 24.67M | -13.46500M | -75.25500M | 844.13M | -46.90500M |
| Change to operating activities | 2.17M | -26.44000M | -14.81800M | -13.53900M | -1.54000M |
| Net income | -15.84200M | 121.43M | 39.79M | 31.88M | 59.81M |
| Change in cash | 15.79M | -16.71900M | 38.34M | 19.13M | 13.38M |
| Begin period cash flow | 165.18M | 181.90M | 143.56M | 124.42M | 111.05M |
| End period cash flow | 180.96M | 165.18M | 181.90M | 143.56M | 124.42M |
| Total cash from operating activities | 41.79M | 48.93M | 178.39M | 82.37M | 78.78M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 80.47M | 86.55M | 83.25M | 44.90M | 19.71M |
| Other cashflows from investing activities | -11.65200M | -27.67300M | -53.48400M | -893.08700M | 0.53M |
| Dividends paid | -30.10300M | -28.59900M | -27.56300M | -21.83000M | 19.32M |
| Change to inventory | -29.85800M | -84.42800M | -3.85400M | 10.84M | -10.54800M |
| Change to account receivables | -59.11200M | -67.47300M | 17.17M | 19.93M | -2.82200M |
| Sale purchase of stock | -0.37800M | 0.89M | 2.82M | 1.37M | 0.08M |
| Other cashflows from financing activities | 729.61M | 53.92M | 2.07M | 874.76M | -0.79500M |
| Change to netincome | 98.01M | -27.38900M | 62.37M | 46.04M | -1.80900M |
| Capital expenditures | 28.54M | 21.46M | 17.90M | 15.54M | 12.89M |
| Change receivables | -59.11200M | -67.47300M | 17.17M | 19.93M | -2.82200M |
| Cash flows other operating | -7.15300M | -23.26900M | 3.09M | -7.23800M | 6.55M |
| Exchange rate changes | - | -3.05700M | 6.59M | 1.26M | -6.14100M |
| Cash and cash equivalents changes | 26.27M | -16.71900M | 38.34M | 19.13M | 13.38M |
| Change in working capital | -112.92400M | -136.34600M | 29.57M | 6.94M | -9.78800M |
| Stock based compensation | 11.67M | 11.04M | 11.00M | 4.86M | 3.72M |
| Other non cash items | 95.38M | -20.31200M | 52.00M | 16.22M | 5.39M |
| Free cash flow | 13.26M | 27.48M | 160.49M | 66.83M | 65.89M |
Sector: Basic Materials Industry: Specialty Chemicals
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| KWR Quaker Chemical Corporation |
-1.93 1.35% | 141.28 | 238.31 | 23.58 | 1.94 | 2.85 | 2.27 | 24.40 |
| LIN Linde plc Ordinary Shares |
11.38 2.27% | 513.30 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
1.48 3.94% | 38.94 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
-0.0037 0.0018% | 210.32 | 30.66 | 24.51 | 4.69 | 4.05 | 4.36 | 15.61 |
| SHW Sherwin-Williams Co |
7.62 2.54% | 307.17 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Quaker Chemical Corporation, doing business as Quaker Houghton, develops, produces, and markets various formulated chemical specialty products for a range of heavy industrial and manufacturing applications in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, metal finishing fluids, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals. The company also provides chemical management services. It serves steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. The company was founded in 1918 and is headquartered in Conshohocken, Pennsylvania.
One Quaker Park, Conshohocken, PA, United States, 19428-2380
| Name | Title | Year Born |
|---|---|---|
| Mr. Andrew E. Tometich | CEO, Pres & Director | 1967 |
| Mr. Shane W. Hostetter | Sr. VP & CFO | 1981 |
| Mr. Wilbert Platzer | Sr. VP of Global Operations, Environmental Health & Safety (?EHS?) and Procurement | 1961 |
| Mr. Joseph A. Berquist | Exec. VP, Chief Strategy Officer and MD of Global Specialty Bus.es & EMEA (Interim) | 1971 |
| Mr. Jeewat Bijlani | Sr. VP & MD of Americas | 1977 |
| Mr. David A. Will | VP, Global Controller & Principal Accounting Officer | 1985 |
| Dr. David H. Slinkman | Sr. VP & CTO | 1965 |
| Mr. Dhruwa Narain Rai | Sr. VP & Chief Information Digital Officer | 1969 |
| Mr. Jeffrey Michael Schnell | Sr. Director of Investor Relations | NA |
| Mr. Robert T. Traub Esq. | Sr. VP, Gen. Counsel & Corp. Sec. | 1965 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...